Avanos Medical (AVNS) Competitors

Avanos Medical (NYSE:AVNS) and Artivion (NYSE:AORT) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

Is AVNS or AORT more profitable?

Artivion has a net margin of -4.43% compared to Avanos Medical's net margin of -66.89%. Avanos Medical's return on equity of 6.16% beat Artivion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-66.89%	6.16%	4.57%
Artivion	-4.43%	5.70%	2.29%

Does the media favor AVNS or AORT?

In the previous week, Artivion had 8 more articles in the media than Avanos Medical. MarketBeat recorded 11 mentions for Artivion and 3 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.82 beat Artivion's score of 0.83 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Artivion	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate AVNS or AORT?

Artivion has a consensus target price of $40.63, suggesting a potential downside of 6.65%. Given Artivion's stronger consensus rating and higher probable upside, analysts plainly believe Artivion is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Artivion	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	3.00

Which has stronger valuation & earnings, AVNS or AORT?

Artivion has lower revenue, but higher earnings than Avanos Medical. Artivion is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$692.50M	0.78	-$392.10M	-$10.07	-1.15
Artivion	$388.54M	5.29	-$13.36M	-$0.42	-103.64

Do insiders & institutionals hold more shares of AVNS or AORT?

95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 86.4% of Artivion shares are owned by institutional investors. 2.6% of Avanos Medical shares are owned by company insiders. Comparatively, 8.1% of Artivion shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more risk & volatility, AVNS or AORT?

Avanos Medical has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Comparatively, Artivion has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500.

Summary

Artivion beats Avanos Medical on 11 of the 17 factors compared between the two stocks.